These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 14998914)

  • 1. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.
    Dalton CM; Chard DT; Davies GR; Miszkiel KA; Altmann DR; Fernando K; Plant GT; Thompson AJ; Miller DH
    Brain; 2004 May; 127(Pt 5):1101-7. PubMed ID: 14998914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
    Chard DT; Griffin CM; Parker GJ; Kapoor R; Thompson AJ; Miller DH
    Brain; 2002 Feb; 125(Pt 2):327-37. PubMed ID: 11844733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of early brain atrophy in clinically isolated syndromes.
    Pérez-Miralles F; Sastre-Garriga J; Tintoré M; Arrambide G; Nos C; Perkal H; Río J; Edo MC; Horga A; Castilló J; Auger C; Huerga E; Rovira A; Montalban X
    Mult Scler; 2013 Dec; 19(14):1878-86. PubMed ID: 23652215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
    Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH
    Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis.
    Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; Miller DH; Thompson AJ
    Neuroimage; 2004 May; 22(1):353-9. PubMed ID: 15110026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability.
    Roosendaal SD; Bendfeldt K; Vrenken H; Polman CH; Borgwardt S; Radue EW; Kappos L; Pelletier D; Hauser SL; Matthews PM; Barkhof F; Geurts JJ
    Mult Scler; 2011 Sep; 17(9):1098-106. PubMed ID: 21586487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional grey matter atrophy in clinically isolated syndromes at presentation.
    Henry RG; Shieh M; Okuda DT; Evangelista A; Gorno-Tempini ML; Pelletier D
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1236-44. PubMed ID: 18469033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.
    Vidal-Jordana A; Sastre-Garriga J; Pareto D; Tur C; Arrambide G; Otero-Romero S; Huerga E; Mitjana R; Auger C; Tintoré M; Rovira A; Montalban X
    Mult Scler; 2018 May; 24(6):721-727. PubMed ID: 28445084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
    Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
    Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis.
    Dalton CM; Brex PA; Jenkins R; Fox NC; Miszkiel KA; Crum WR; O'Riordan JI; Plant GT; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):141-7. PubMed ID: 12122170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
    Jacobsen C; Hagemeier J; Myhr KM; Nyland H; Lode K; Bergsland N; Ramasamy DP; Dalaker TO; Larsen JP; Farbu E; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1109-15. PubMed ID: 24554101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.
    Di Filippo M; Anderson VM; Altmann DR; Swanton JK; Plant GT; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):204-8. PubMed ID: 19744964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
    Brownlee WJ; Solanky B; Prados F; Yiannakas M; Da Mota P; Riemer F; Cardoso MJ; Ourselin S; Golay X; Gandini Wheeler-Kingshott C; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):755-760. PubMed ID: 30948625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.